We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors’ Share Purchases and Share Options

28 Oct 2020 16:00

RNS Number : 5221D
Zoetic International PLC
28 October 2020
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

28 October 2020

 

Zoetic International plc

 

("Zoetic" or the "Company" or the "Group")

 

Directors' Share Purchases and Share Options

 

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, has today been informed that its two directors, Trevor Taylor and Antonio Russo, have each agreed to purchase 500,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") from an existing shareholder at a price of US$0.51 (approximately 39p) per Ordinary Share (the "Transactions"). The Transactions are being undertaken off-market and are expected to complete within the next two weeks.

 

Mr Taylor and Mr Russo each currently hold 6,450,000 Ordinary Shares, and following the Transactions, will each hold 6,950,000 Ordinary Shares, equivalent to approximately 3.57 per cent of the currently issued Ordinary Shares.

 

The Company announced on 8 October 2019 the introduction of a new share option scheme (the "Scheme"), under which options were granted over 7,155,000 Ordinary Shares at an exercise price of 10 pence per Ordinary Share (the "Options"). Since that date certain Option holders have left the service of the Group and 5,775,000 of the Options have been returned to the Option pool. These returned Options have today been reassigned equally to Trevor Taylor and Antonio Russo on their original terms. Under these original terms, the Options shall vest over three years from the date of grant (8 October 2019) subject to continued employment and these performance conditions:

 

1. 50 per cent of the Options will vest at any time after the second anniversary of grant if the 30-day volume-weighted price of the Company's ordinary shares ("VWAP") is 14 pence or more per Ordinary Share;

2. a further 50 per cent of the Options will vest at any time after the second anniversary of grant if the 30-day VWAP is 18 pence or more per Ordinary Share, this part of the award will vest in full; and 

3. if condition (2) is not satisfied but, by the third anniversary of grant, the VWAP is between 14 pence and 18 pence per Ordinary Share, the remaining Options will vest on a pro-rated straight-line basis (or will otherwise lapse).

 

Once vested, the Options expire on the tenth anniversary of the date of grant (8 October 2029) if not exercised.

 

Mr Taylor and Mr Russo each hold 190,000 existing Options under the Scheme.

 

**ENDS**

Enquiries

 

Zoetic International plc c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSEIILTFII
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.